• Britain's Prime Minister Boris Johnson holds a vial of the Oxford/AstraZeneca vaccine during a visit to Barnet FC's ground, which is being used as a coronavirus vaccination centre in London. AP Photo
    Britain's Prime Minister Boris Johnson holds a vial of the Oxford/AstraZeneca vaccine during a visit to Barnet FC's ground, which is being used as a coronavirus vaccination centre in London. AP Photo
  • Boris Johnson meets staff and patients at Barnet FC's ground. Reuters
    Boris Johnson meets staff and patients at Barnet FC's ground. Reuters
  • Boris Johnson watches a patient receiving a dose of the Oxford/AstraZeneca vaccine at Barnet FC's ground. Reuters
    Boris Johnson watches a patient receiving a dose of the Oxford/AstraZeneca vaccine at Barnet FC's ground. Reuters
  • A worker digs a grave in a cemetery in Manchester. Reuters
    A worker digs a grave in a cemetery in Manchester. Reuters
  • Robert Ward, 56, a retired nurse from Blackpool Victoria Hospital, injects a patient with a dose of the Oxford/AstraZeneca vaccine during a clinic at the Winter Gardens in Blackpool. AFP
    Robert Ward, 56, a retired nurse from Blackpool Victoria Hospital, injects a patient with a dose of the Oxford/AstraZeneca vaccine during a clinic at the Winter Gardens in Blackpool. AFP
  • Members of the public queue to enter a new coronavirus mass vaccination centre at Stratford shopping centre in east London. AFP
    Members of the public queue to enter a new coronavirus mass vaccination centre at Stratford shopping centre in east London. AFP
  • A woman wearing a face mask crosses London Bridge. Reuters
    A woman wearing a face mask crosses London Bridge. Reuters
  • People exercise along the bank of the River Thames in London. AP Photo
    People exercise along the bank of the River Thames in London. AP Photo
  • A cyclist wears a mask as he passes graffiti in London during England's third national lockdown. AP Photo
    A cyclist wears a mask as he passes graffiti in London during England's third national lockdown. AP Photo
  • Pedestrians walk in St James' park in London. A national lockdown across England began on midnight on 5 January. EPA
    Pedestrians walk in St James' park in London. A national lockdown across England began on midnight on 5 January. EPA
  • Police speak to pedestrians sitting in Trafalgar Square in London. EPA
    Police speak to pedestrians sitting in Trafalgar Square in London. EPA
  • People take daily exercise at Primrose Hill, north London. AFP
    People take daily exercise at Primrose Hill, north London. AFP
  • People walk past shops and market stalls in east London. Reuters
    People walk past shops and market stalls in east London. Reuters
  • People wearing protective face coverings walk in the snow on Primrose Hill in London. AFP
    People wearing protective face coverings walk in the snow on Primrose Hill in London. AFP
  • A man wearing a face mask walks past a instructional government sign in London. Reuters
    A man wearing a face mask walks past a instructional government sign in London. Reuters

UK cases of South African virus strain rise to 77 amid fears it could be more deadly


Simon Rushton
  • English
  • Arabic

Britain is detecting a rising number of cases of the South African Covid-19 mutation, the country's health minister said.
Three days ago, the government's chief scientific adviser, Sir Patrick Vallance, said there were 44 confirmed cases of the South African strain in the UK.  By Monday, the figure had risen to 77.
Experts fear the variants, including one first identified in south-east England, are more contagious and potentially more deadly, with greater resistance to vaccines.

UK Health Secretary Matt Hancock said that all 77 cases were connected to travel from South Africa and were being monitored, as were nine identified cases of a Brazilian variant.

"They are under very close observation and we have enhanced contact tracing to do everything we possibly can to stop them from spreading," he said.

“The new variant I really worry about is the one that’s out there but hasn’t been spotted.

Mr Hancock said the new variants "might have a lower response to the vaccine", particularly in South Africa and Brazil.

"Now, we don’t know the degree of that but we are looking into it, both at Porton Down [research laboratory] and also in South Africa," he said.

“We actually have a trial in the field to see how well the Oxford vaccine works in South Africa.

"But in the meantime, we’ve got to have a precautionary principle that says, ‘let’s not bring these new variants back to the UK’.”

Oxford university professor Anthony Harnden said the South African and Brazilian variants were of concern because Covid-19 vaccines may not be effective against them.

"The new variants abroad are a real worry. The South African and the Brazilian Amazonian ones, there are hints that there will be vaccine escape," he said, adding that new variants would keep appearing around the world.